<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet type='text/xsl' href='https://cllmonitor.it/wp-content/plugins/google-sitemap-generator/sitemap.xsl'?><!-- sitemap-generator-url='http://www.arnebrachhold.de' sitemap-generator-version='4.1.24' -->
<!-- generated-on='20 August 2026 13:11' -->
<urlset xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd' xmlns='http://www.sitemaps.org/schemas/sitemap/0.9'>	<url>
		<loc>https://cllmonitor.it/al-passo-con-la-ricerca-scientifica/</loc>
		<lastmod>2021-12-15T14:06:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/progetto-digitale-cll-monitor/</loc>
		<lastmod>2021-12-15T14:06:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/presentazione-di-cll-monitor/</loc>
		<lastmod>2021-12-22T15:56:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/benvenuti-in-cll-monitor-sondaggio-preferenze-terapie-in-prima-linea/</loc>
		<lastmod>2021-12-22T13:58:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/trattamento-di-riferimento-risultati-commento/</loc>
		<lastmod>2021-12-15T14:31:23+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/fitness-di-un-paziente-affetto-da-cll/</loc>
		<lastmod>2021-12-15T14:30:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/fitness-di-un-paziente-affetto-da-cll-leggi-i-risultati/</loc>
		<lastmod>2021-12-22T13:50:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/ash-2021-quali-novita-ti-aspetti/</loc>
		<lastmod>2021-12-22T13:56:52+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/astudio-gaia-take-home-message-rispondi-al-sondaggio/</loc>
		<lastmod>2021-12-22T15:56:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/ash-session-presentations-abstracts-cll/</loc>
		<lastmod>2021-12-21T17:02:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/ash-2021-risultati-commento-sondaggio/</loc>
		<lastmod>2021-12-22T11:23:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/studi-captivate-e-glow-combinazione-ibrutinib-venetoclax-in-prima-linea/</loc>
		<lastmod>2021-12-22T15:56:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/studi-captivate-glow-gaia-risultati-e-commento-ai-sondaggi/</loc>
		<lastmod>2022-01-28T15:41:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/partecipa-al-sondaggio-inibitori-reversibili-di-btk-pirtobrutinib-nemtabrutinib/</loc>
		<lastmod>2022-01-28T15:41:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/inibitori-reversibili-btk-pirtobrutinib-nemtabrutinib-risultati-commento-al-sondaggio/</loc>
		<lastmod>2022-01-28T15:41:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/analisi-biologica-al-momento-della-diagnosi-di-cll/</loc>
		<lastmod>2022-02-10T11:38:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/tecniche-di-imaging-al-momento-diagnosi-cll/</loc>
		<lastmod>2022-02-10T11:38:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/analisi-biologica-al-momento-della-diagnosi-di-cll-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2022-02-16T08:27:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/tecniche-di-imaging-al-momento-della-diagnosi-di-cll-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2022-02-16T08:27:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/analisi-biologica-linee-successive/</loc>
		<lastmod>2022-03-04T14:53:04+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/analisi-biologica-prima-linea/</loc>
		<lastmod>2022-03-04T14:52:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/analisi-biologica-prima-linea-e-linee-successive-risultati-e-commento-ai-sondaggi/</loc>
		<lastmod>2022-03-17T11:06:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/imaging-in-fu-terapie-successive/</loc>
		<lastmod>2022-04-01T14:39:51+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/imaging-followup-terapie-successive-risultati/</loc>
		<lastmod>2022-04-06T07:34:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-pz-piastrinopenia/</loc>
		<lastmod>2022-04-20T11:15:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/piastrinopenia-risultati-nuovo-quesito/</loc>
		<lastmod>2022-05-02T13:03:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-anemia2/</loc>
		<lastmod>2022-05-16T12:51:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-anemia-risultati-e-commento/</loc>
		<lastmod>2022-05-24T09:22:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-paziente-con-linfoadenomegalie/</loc>
		<lastmod>2022-06-15T09:35:32+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-paziente-con-linfoadenomegalie-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2022-06-17T10:37:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/novita-sulla-cll-da-eha-2022/</loc>
		<lastmod>2022-07-07T14:20:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/novita-sulla-cll-da-eha-2022-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2022-07-20T09:46:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-trattamento-prima-linea-paziente-fit/</loc>
		<lastmod>2022-08-04T09:22:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/cll-monitor-i-vostri-suggerimenti-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2022-09-14T13:00:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/cll-monitor-i-vostri-suggerimenti/</loc>
		<lastmod>2022-09-12T08:32:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-trattamento-prima-linea-paziente-fit-risultati-e-commento-al-sondaggio-2/</loc>
		<lastmod>2022-09-12T08:33:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-terapia-di-prima-linea-e-comorbodita/</loc>
		<lastmod>2022-10-18T11:04:36+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-terapia-di-prima-linea-e-comorbidita-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2022-10-24T11:43:08+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-sliding-doors-nella-terapia-di-prima-linea/</loc>
		<lastmod>2022-11-21T10:53:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-sliding-doors-nella-terapia-di-prima-linea-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2022-11-25T14:33:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-trapianto-o-non-trapianto-questo-e-il-dilemma/</loc>
		<lastmod>2023-01-04T10:03:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-trapianto-o-non-trapianto-questo-e-il-dilemma-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-01-13T09:07:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/take-home-messages-dall-ash-2022/</loc>
		<lastmod>2023-02-03T14:19:27+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/take-home-messages-da-ash-2022-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-02-07T12:09:59+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-effetti-off-target-in-corso-di-terapia-con-btki/</loc>
		<lastmod>2023-02-27T16:46:21+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-effetti-off-target-in-corso-di-terapia-con-btki-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-03-02T16:44:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-un-ramp-up-complicato/</loc>
		<lastmod>2023-03-13T16:03:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-un-ramp-up-complicato-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-03-17T15:41:10+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-obinutuzumab-adverse-events/</loc>
		<lastmod>2023-04-03T08:02:39+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-obinutuzumab-adverse-events-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-04-06T15:09:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-warm-autoimmune-hemolytic-anemia-in-paziente-con-cll/</loc>
		<lastmod>2023-04-26T08:46:33+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-warm-autoimmune-hemolytic-anemia-in-paziente-con-cll-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-04-26T09:14:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-btki-e-artralgie/</loc>
		<lastmod>2023-05-12T13:00:17+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-btki-e-artralgie-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2024-01-22T11:19:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-sindrome-di-richter-approccio-diagnostico-e-terapeutico/</loc>
		<lastmod>2023-06-01T15:27:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-sindrome-di-richter-approccio-diagnostico-e-terapeutico-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-06-07T15:14:55+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-inibitori-non-covalenti-di-btk/</loc>
		<lastmod>2023-06-29T16:32:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-inibitori-non-covalenti-di-btk-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-07-03T16:30:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-treatment-choice-on-cll/</loc>
		<lastmod>2023-07-26T15:00:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-treatment-choice-on-cll-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-08-30T15:21:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/cll-monitor-day-evento-20-novembre-2023/</loc>
		<lastmod>2023-09-14T16:11:50+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/cll-monitor-day-evento-20-novembre-2023-2/</loc>
		<lastmod>2023-09-19T10:55:11+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-paziente-con-ipogammaglobulinemia-secondaria/</loc>
		<lastmod>2023-09-29T15:31:14+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-paziente-con-ipogammaglobulinemia-secondaria-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-10-06T13:15:01+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-nuovi-agenti-terapeutici-e-profilassi/</loc>
		<lastmod>2023-10-27T10:54:57+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-nuovi-agenti-terapeutici-e-profilassi-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2023-12-01T16:36:24+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-trattamento-prima-linea-in-giovane-paziente-fit/</loc>
		<lastmod>2024-01-09T08:44:54+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-trattamento-prima-linea-in-giovane-paziente-fit-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2024-01-26T15:31:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-rechallenge-btki/</loc>
		<lastmod>2024-03-11T14:46:47+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-rechallenge-btki-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2024-02-20T08:25:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-piastrinopenia-in-cll/</loc>
		<lastmod>2024-03-11T14:46:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-piastrinopenia-in-cll-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2024-03-11T14:46:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-neutropenia-in-cll/</loc>
		<lastmod>2024-04-03T14:28:16+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-neutropenia-in-cll-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2024-03-28T10:31:29+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-cefalea-e-rash/</loc>
		<lastmod>2024-04-29T15:53:46+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-cefalea-e-rash-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2024-04-30T13:55:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-terapia-di-prima-linea/</loc>
		<lastmod>2024-05-23T11:09:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-terapia-di-prima-linea-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2024-05-29T14:44:37+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-tossicita-iv/</loc>
		<lastmod>2024-08-02T09:25:20+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-tossicita-iv-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2024-08-30T10:36:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-relapse-dopo-iv/</loc>
		<lastmod>2024-09-23T15:31:41+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-relapse-dopo-iv-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2024-09-18T12:47:09+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-cll-ecovid-19/</loc>
		<lastmod>2025-01-24T12:15:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-cll-e-covid-19-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-01-24T12:14:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-relapse-dopo-vo/</loc>
		<lastmod>2025-01-24T12:14:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-relapse-dopo-vo-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-01-24T12:15:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-linfatica-cronica-accelerata/</loc>
		<lastmod>2025-01-31T10:18:40+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-linfatica-cronica-accelerata-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-01-31T10:25:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-btki-2-generazione-acalabrutinib-vs-zanubrutinib/</loc>
		<lastmod>2025-03-03T15:31:18+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-btki-2-generazione-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-02-28T16:16:22+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-uno-sguardo-al-futuro-con-nuove-potenziali-combinazioni/</loc>
		<lastmod>2025-03-25T12:27:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-uno-sguardo-al-futuro-con-nuove-potenziali-combinazioni-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-03-28T11:00:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-prova-dimensione-finestra-sondagigo/</loc>
		<lastmod>2025-04-04T13:12:44+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-paziente-r-r/</loc>
		<lastmod>2025-05-12T11:50:48+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-paziente-r-r-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-05-13T09:10:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-monitoraggio-in-corso-di-terapia/</loc>
		<lastmod>2025-06-06T08:09:12+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-monitoraggio-in-corso-di-terapia-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-06-06T08:20:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-management-high-risk-cll/</loc>
		<lastmod>2025-07-09T07:55:19+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-management-high-risk-cll-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-07-11T10:19:06+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-il-ruolo-dellallogenico-nel-sequencing-moderno/</loc>
		<lastmod>2025-09-18T08:16:28+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-ruolo-dellallogenico-nel-sequencing-moderno-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-09-18T08:24:13+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-richter-transformation/</loc>
		<lastmod>2025-10-16T14:48:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-richter-transformation-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-10-16T14:55:26+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-pirtobrutinib-aes/</loc>
		<lastmod>2025-11-13T13:42:15+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-pirtobrutinib-aes-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2025-11-13T14:17:45+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-tossicita-in-corso-di-iv-2/</loc>
		<lastmod>2026-02-10T19:47:49+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-tossicita-in-corso-di-iv-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2026-02-13T12:28:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-terapia-di-prima-linea-paziente-anziano-fit/</loc>
		<lastmod>2026-03-18T14:54:00+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-terapia-di-prima-linea-paziente-anziano-fit-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2026-03-20T11:33:56+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-terapia-di-prima-linea-paziente-giovane-fit/</loc>
		<lastmod>2026-04-24T08:51:30+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-terapia-di-prima-linea-paziente-giovane-fit-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2026-04-30T09:39:38+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-sequencing-dopo-cbtki/</loc>
		<lastmod>2026-05-29T16:40:25+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-sequencing-dopo-cbtki-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2026-06-11T15:32:05+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-il-trattamento-di-prima-linea-oltre-il-profilo-biologico/</loc>
		<lastmod>2026-07-08T15:45:35+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
	<url>
		<loc>https://cllmonitor.it/caso-clinico-il-trattamento-di-prima-linea-oltre-il-profilo-biologico-risultati-e-commento-al-sondaggio/</loc>
		<lastmod>2026-07-20T14:26:03+00:00</lastmod>
		<changefreq>monthly</changefreq>
		<priority>0.2</priority>
	</url>
</urlset><!-- Request ID: c34a944b1fa417218f52f2f057e5789b; Queries for sitemap: 4; Total queries: 134; Seconds: 0.01; Memory for sitemap: 1KB; Total memory: 124MB -->
